December  2023

No Study Name/Phase Type Sponsor Population (Gender/Age) Enrolled / (Target if still enrolling) Period
Setshaba Research Centre: Site Initiated Research
1  

Vaccine Hesitancy

click to read more

Behavioural SRC ♂/♀≥18 n/a 2022
2 HVTN 702/705 Mapping   click to read more Behavioural SRC ♂/♀18-35 yrs n/a 2020-2021
  Other Projects
3 R01 AI147681 KHARITUWE TB MIGRATION STUDY TB Tracing John Hopkins University ♂/♀ 0-99 yrs target 7200 2020 – 2025
4 212171 (RSV MAT-009) RSV Vaccine GSK ♀  18 – 49 Target 250 2021 – 2023
5 HVTN RAMP Behavioural HVTN MSM &Transgender ♂ ≥18;

Transgender ♀ ≥18

200 May 2021 – May 2022
6  

GS-US-412-5624 (PURPOSE 1)

HIV PrEP study Gilead Cisgender ♀
16 – 35
200 Nov/2021 – Jun/2026
7 HVTN 139 Phase 1 HIV Vaccine Study HVTN ♂+♀18 through to 50 years 6 Nov/2021 – Dec/2023
8 Pfizer RSV Phase 3 RSV Vaccine Pfizer ♂+♀
≥ 60
100 Nov/2021 – Dec/2022
9 Gates MRI TBV02-EO1 Epidemiology Bill and Melinda Gates ♂+♀15 – 34 160 Jan 2022 – Jun 2025
10 GO-012 Covid Vaccine Gritstone Bio ♂+♀18 – 64 94 Mar 2022 – Mar 2023
11 323-201-00006_Otsuka Trial – 2b/c TB Oral treatment Study Clindev ♂+♀ 18-65 15 APR/2022-APR/2024
12 GS-US-528-9023_(Purpose 2) HIV PrEP study Gilead Cisgender ♀

16 – 35

75 Jul 2022 – 2026
13 VAC31518COV3006_Horizon 2 Covid Vaccine Janssen <12 years

≥18

19 Jun 2022 – Jun 2024
14 GBS_MVX0004 Group B Streptococcus MinerVax/OnQ

18 years and older

50 Aug 2022-Aug 2023
15 RSV-MAT 015 Observational study GSK

18 – 49

150 Mar 2023 – 2024
16 Pfizer Flu (C4781004) Flu vaccine study Pfizer ♂+♀ 65 years and above Target 200

Enrolled

208

Jun 2023-2024
17 NC009 TB Study TB Alliance ♂+♀ 18 – 65 years Target 15

Enrolled

3

Oct 2023 –Nov 2024